Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2083

Amgen and AstraZeneca share positive results in chronic rhinosinusitis

$
0
0
Amgen and AstraZeneca said on Friday that their asthma drug Tezspire reduced nasal congestion and the size of nasal polyps in patients with a different but sometimes related inflammatory condition. Tezspire, also known as tezepelumab ...

Viewing all articles
Browse latest Browse all 2083

Trending Articles